middle.news
Neurizon opens A$2 million SPP with free options ahead of ALS milestone
8:50am on Monday 16th of November, 2026 AEDT
•
Biotechnology
Read Story
Neurizon opens A$2 million SPP with free options ahead of ALS milestone
8:50am on Monday 16th of November, 2026 AEDT
Key Points
A$2 million non-underwritten SPP at A$0.068 per share
Eligible Australian and New Zealand shareholders can apply for up to A$30,000
One potential free option for each SPP share, exercisable at A$0.12
Funds earmarked for the HEALEY ALS trial and NUZ-001 preparation
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Neurizon Therapeutics (ASX:NUZ)
OPEN ARTICLE